Efficacy and safety of switching from intravenous to subcutaneous CTP-13 treatment in IBD patients – a one-year retrospective study from large Slovak IBD centre
Original articleGastroent Hepatol 2024; 78(1): 31–36. doi: 10.48095/ccgh202431
SummaryLiteraturepdf Anna Gojdičová, Igor Šturdík, Jozef Tóth, Marek Gojdič, Zuzana Vrablicová, Iveta Čierna, Dagmar Szekyová, Alena Krónerová, Tibor Hlavatý